Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
11.23
+0.48 (4.47%)
Nov 22, 2024, 4:00 PM EST - Market closed
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ETON stock have an average target of 12, with a low estimate of 10 and a high estimate of 15. The average target predicts an increase of 6.86% from the current stock price of 11.23.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ETON stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -2.05% | Nov 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +33.57% | Oct 28, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | -10.95% | Oct 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | -2.05% | Oct 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | -19.86% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
37.85M
from 31.64M
Increased by 19.61%
Revenue Next Year
69.15M
from 37.85M
Increased by 82.71%
EPS This Year
-0.18
from -0.04
EPS Next Year
0.54
from -0.18
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 39.6M | 75.0M | 96.3M |
| Avg | 37.8M | 69.2M | 93.6M |
| Low | 35.8M | 62.9M | 89.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 25.1% | 98.1% | 39.3% |
| Avg | 19.6% | 82.7% | 35.3% |
| Low | 13.0% | 66.2% | 30.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.18 | 0.61 | 1.03 |
| Avg | -0.18 | 0.54 | 1.00 |
| Low | -0.18 | 0.47 | 0.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 90.3% |
| Avg | - | - | 84.9% |
| Low | - | - | 77.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.